Military Cardiovascular Outcomes Research program ( MiCOR )

The Military Cardiovascular Outcomes Research program (MiCOR) is located at the Uniformed Services University of the Health Sciences in Bethesda, Maryland. MiCOR is a multidisciplinary...

Brief Research Program Description

The Military Cardiovascular Outcomes Research program (MiCOR) is located at the Uniformed Services University of the Health Sciences in Bethesda, Maryland. MiCOR is a multidisciplinary program that performs randomized clinical trials of novel prevention and treatment approaches to decrease the risk of cardiovascular disease in active-duty military personnel, retirees, and their dependents due to conditions including, but not limited to, combat injury, sleep disorders, eating disorders, and COVID-19. The mission of the MiCOR Program is to enhance the cardiovascular health and well-being of the Warfighter and the DoD community through innovative clinical research using precision techniques. MiCOR has a variety of clinical research studies focused on both the biomedical and behavioral components that contribute to cardiovascular risk and disease.

List of the team’s Publications/ Accomplishments Overview

The most notable accomplishments of 2022-2023 are outlined below (to date/2022-2023):

Peer-Reviewed Publications: 116/74
Book Chapters: 13/4; Books: 1/0
Invited Presentations: 36/19
Congressional Briefings: 3/1
Guidelines: 2/1
Between Jun2022 and Oct2022, as directed by 2022 NDAA Section 733, we screened 3,531 Academy first year Cadets. This resulted in 43 abnormal ECGs: 34 False Positive (rate 0.94%) in which the ECG was POSITIVE but follow on testing showed no disorder was present. 7 DISQUALIFIED, but effectively treated with 100% RTD. Additional 1200 cadets screened in July 2023. Briefed OASD (HA) 22FEB2023; Cardiovascular Clinical Community (CVCC) briefed 21FEB2023; Brief submitted to House Armed Services Committee (HASC) April 2023; Pending brief to Accessions Medical Standards Working Group (AMSWG) 05OCT2023.
10 studies in active enrollment phase and protocol execution phase focused on cardiac arrest, obesity prevention, and cardiac impact of COVID-19
5 studies completed protocol execution and are in analysis focused on obesity prevention, pharmacogenomics, COVID arrhythmia
7 studies in or through institutional review and preparing for enrollment phase.
5 studies in protocol development phase.